Threshold Pharmaceutical Inc (THLD)

Threshold is a biotechnology company focusing on the development of cancer treatment drugs. The company’s product candidates include Glufosfamide, for the treatment of pancreatic, ovarian, and small cell lung cancer; 2DG for the treatment of solid tumors; and TH-302, also for the treatment of solid tumors.

Show Chart

Events

  • September122010
    Threshold Pharmaceuticals Inc. Presents at Annual Global Investment Conference - 12th Annual Healthcare Conference, Sep-14-2010 04:55 PM
  • November 52010
    Threshold Pharmaceuticals Inc. expected to report Q3 2010 results on November 5, 2010. This event was calculated by Capital IQ (Created on August 7, 2010).
  • March 62011
    Threshold Pharmaceuticals Inc. expected to report Fiscal Year 2010 results on March 6, 2011. This event was calculated by Capital IQ (Created on June 27, 2010).

Members who own this company also own

the fun, safe & free way to learn the stock market Free! Sign up now! or log in

Current price per share

Today's gain: $0.02 (1.60%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon

Sign up or Sign in or continue to Explore We Seed